‘Heretical’ Rule Changes Could Make More Drugs Available OTC In US – Former NDAC Chair Brass

 
• By Malcolm Spicer
  
OTC drug marketers do “a balancing act” to include necessary information on DFLs without overwhelming consumers with too much while also complying with FDA requirements. • Source: Eric Brass/FDA webinar

More from Regulation

More from Policy & Regulation